TB & Outbreaks Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB & Outbreaks Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Neutropenia
Research from Erasmus University reveals new findings on neutropenia
May 27th, 2008
According to a study from Rotterdam, Netherlands, "Invasive pulmonary aspergillosis ( IPA) is a significant problem in patients with chemotherapy-induced prolonged neutropenia. Because pulmonary deposition of conidia is the first step in developing IPA, we hypothesized that inhalation of liposomal amphotericin B would prevent IPA." "We performed a randomized, placebo- controlled trial of patients with hematologic disease with expected neutropenia for >= 10 days. Patients were randomized to receive liposomal amphotericin B or placebo inhalation twice a week, using an adaptive aerosol delivery system, until neutrophil counts increased to >300 cells/ mm(3). In...
Source: TB & Outbreaks Week (2008-05-27)
|
